Concepedia

Yi Ren

YR

Statistics

Publications

18

Citations

674

H-Index

15

Active since

2011

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Roche (China)

Hunan Normal University

Tibet Autonomous Region People's Hospital

Yi Ren is an author at Center for Drug Evaluation and Research specializing in pharmacology, oncology, and molecular oncology.

ORCID

Publications per year

2011–2025

18

Publications

18

Defect of branched-chain amino acid metabolism promotes the development of Alzheimer’s disease by targeting the mTOR signaling

Huajie Li, Dan Ye, Wei Xie et al. · Bioscience Reports · 2018 · 90 citations · Full text

, , +13

Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma

Huibin Song, Dongcheng Liu, Lingwei Wang et al. · Molecular Cancer · 2022 · 86 citations · Full text

, , +17

FDA Approval Summary: Dabrafenib in Combination with Trametinib for <i>BRAF</i>V600E Mutation–Positive Low-Grade Glioma

Michael I. Barbato, Jeannette Nashed, Diana Bradford et al. · Clinical Cancer Research · 2023 · 71 citations · Full text

, , +14

Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial

Bo Yang, Xiangyu Gao, Yi Ren et al. · Experimental and Therapeutic Medicine · 2016 · 69 citations · Full text

, , +17

Placental Growth Factor Upregulation Is a Host Response to Antiangiogenic Therapy

Rebecca G. Bagley, Yi Ren, William Weber et al. · Clinical Cancer Research · 2011 · 58 citations

, , +15

1–5 of 18